Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5426_Библиотеки_им_академика_М_И_Перельмана
.pdf
ab
20 Hypoxia Pathway: 18F- FAZA
https://t.me/med1917
dc
329
Fig. 20.5 18F-FAZA PET/CT and MRI guide biopsy of brain lesion
both high-perfusion MRI markers and high
18F-FAZA uptake was selected for biopsy after
appropriate image fusion (D). The histological
analysis conrmed the presence of a grade IV
glioblastoma.
Images from database of Nuclear Medicine
Department, IRCCS San Raffaele Scientic
Institute, Milan, Italy.
Acknowledgments This work was supported by the
Italian Ministry of Health, Ricerca Finalizzata
(GR-2009the Italian Association for Cancer Research (grant IG
2014 Id.1524; EudraCT:2015-000679-28).
1575612; EudraCT: 2011-002647-98) and by
330
https://t.me/med1917
P. Alongi et al.
References
1. Ruan K, Song G, Ouyang G. Role of hypoxia in
the hallmarks of human cancer. J Cell Biochem.
2009;107:1053.
Joyce JA, Pollard JW.Microenvironmental regulation
2.
of metastasis. Nat Rev Cancer. 2009;9:239.
doi.org/10.1038/nrc2618
Denko NC.Hypoxia, HIF1 and glucose metabolism
3.
in the solid tumour. Nat Rev Cancer. 2008;8:705.
https://doi.org/10.1038/nrc2468.
Pouysségur J, Dayan F, Mazure NM. Hypoxia sig-
4.
nalling in cancer and approaches to enforce tumour
regression. Nature. 2006;441:437.
org/10.1038/nature04871
Harris AL. Hypoxia—a key regulatory factor in
5.
tumour growth. Nat Rev Cancer. 2002;2:38.
doi.org/10.1038/nrc704
Semenza GL.Evaluation of HIF-1 inhibitors as anti-
6.
cancer agents. Drug Discov Today. 2007;12:853.
https://doi.org/10.1016/j.drudis.2007.08.006.
Nguyen DX, Bos PD, Massagué J.Metastasis: from
7.
dissemination to organ-specic colonization. Nat Rev
Cancer. 2009;9:274.
Chandel NS, Simon MC. Hypoxia-inducible factor:
8.
roles in development, physiology, and disease. Cell
Death Differ. 2008;15:619.
cdd.2008.11
Cao Y.Observation of incipient tumor angiogenesis
9.
that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res. 2005;65:5498.
https://doi.org/10.1158/0008- 5472.CAN- 04- 4553.
Krishnamachary B. Regulation of colon carcinoma
10.
cell invasion by hypoxia-inducible factor 1. Cancer
Res. 2003;63:1138.
Le QT, Courter D.Clinical biomarkers for hypoxia
11.
targeting. Cancer Metastasis Rev. 2008;27:351.
https://doi.org/10.1007/s10555- 008- 9144- 9.
Lundgren K, Holm C, Landberg G. Hypoxia and
12.
breast cancer: prognostic and therapeutic implications. Cell Mol Life Sci. 2007;64:3233.
org/10.1007/s00018-
Kumar P, Stypinski D, Xia H, McEwan AJB, Machulla
13.
H, Wiebe LI.Fluoroazomycin arabinoside (FAZA):
synthesis, 2H and 3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker
of tissue hypoxia. J Label Compd Radiopharm.
1999;42:3.
1344(199901)42:1<3::aid- jlcr160>3.3.co;2- 8.
Savi A. First evaluation of PET-based human bio-
14.
distribution and dosimetry of
imaging tumor hypoxia. J Nucl Med. 2017;58:1224.
https://doi.org/10.2967/jnumed.113.122671.
Wack LJ, et al. Comparison of [18F]-FMISO,
15.
18
F]-FAZA and [18F]-HX4 for PET imag-
[
ing of hypoxia—a simulation study. Acta Oncol.
https://doi.org/10.1002/jcb.22214.
.
.
.
https://doi.org/10.1038/nrc2622.
https://doi.org/10.1038/
.
007- 7390- 6.
https://doi.org/10.1002/(sici)1099-
18
F-FAZA, a tracer for
https://
https://doi.
https://
https://doi.
2015;54:1370.
86X.2015.1067721
Provost C, Mammar H, Belly-Poinsignon A, Madar
16.
https://doi.org/10.3109/02841
.
O, Champion L. Pharmacokinetic analysis of [
FAZA dynamic PET imaging acquisitions for highlighting sacrum tumor proles. Clin Nucl Med.
2020 Jan;45(1):e36–8.
RLU.0000000000002813
Mapelli P. 18F-FAZA PET/CT in pretreatment
17.
https://doi.org/10.1097/
.
assessment of hypoxic status in high-grade glioma:
correlation with hypoxia immunohistochemical biomarkers. Nucl Med Commun. 2021;42:763.
doi.org/10.1097/MNM.0000000000001396
Postema EJ.Initial results of hypoxia imaging using
18.
1-α-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)2-nitroimidazole (
Imaging. 2009;36:1565.
009- 1154- 5.
s00259-
Bruine De Bruin L. Assessment of hypoxic
19.
subvolumes in laryngeal cancer with
18F-uoroazomycinarabinoside (
18
F-FAZA). Eur J Nucl Med Mol
https://doi.org/10.1007/
18
https://
.
F-FAZA)-PET/
CT scanning and immunohistochemistry. Radiother
Oncol. 2015;117:106.
radonc.2015.07.012
Mapelli P. Hypoxia 18F-FAZA PET/CT imaging in
20.
https://doi.org/10.1016/j.
.
lung cancer and high-grade glioma: open issues in clinical application. Clin Translat Imaging. 2017;5:389.
https://doi.org/10.1007/s40336- 017- 0240- 0.
Muzi M. 18F -uoromisonidazole quantication
21.
of hypoxia in human cancer patients using imagederived blood surrogate tissue reference regions. J
Nucl Med. 2015;56:1223.
jnumed.115.158717
Kawai N. Correlation between 18F -uoromisonida-
22.
.
https://doi.org/10.2967/
zole PET and expression of HIF-1α and VEGF in
newly diagnosed and recurrent malignant gliomas.
Eur J Nucl Med Mol Imaging. 2014;41:1870.
doi.org/10.1007/s00259-
Bittner MI.Analysis of relation between hypoxia PET
23.
014- 2776- 9.
https://
imaging and tissue-based biomarkers during head and
neck radiochemotherapy. Acta Oncol. 2016;55:1299.
https://doi.org/10.1080/0284186X.2016.1219046.
Grosu AL. Hypoxia imaging with FAZA-PET and
24.
theoretical considerations with regard to dose painting for individualization of radiotherapy in patients
with head and neck cancer. Int J Radiat Oncol
Biol Phys. 2007;69:541.
ijrobp.2007.05.079
Mortensen LS. FAZA PET/CT hypoxia imaging in
25.
.
https://doi.org/10.1016/j.
patients with squamous cell carcinoma of the head
and neck treated with radiotherapy: results from the
DAHANCA 24 trial. Radiother Oncol. 2012;105:14.
Mapelli P. 18F-FAZA PET/CT hypoxia imaging of
26.
high-grade glioma before and after radiotherapy. Clin
Nucl Med. 2017;42:e525.
RLU.0000000000001850
https://doi.org/10.1097/
.
18
F]
Соседние файлы в папке Библиотека им академика М.И. Перельмана